Table 3.
Characteristics of AE reports associated with HBV from VEARS between 1990–2023.
| Characteristics | N | Proportion (%) | |
|---|---|---|---|
| Total | 54,136 | 100% | |
| Gender | Male | 19,862 | 36.69% |
| Female | 30,657 | 56.63% | |
| Unknown | 3617 | 6..68% | |
| Age(year) | ≤ 1 | 15,638 | 28.79% |
| > 1, < 2 | 2650 | 4.88% | |
| ≥ 2, < 12 | 6287 | 11.61% | |
| ≥ 12, < 22 | 7418 | 13.70% | |
| ≥ 22, < 42 | 12,933 | 23.81% | |
| ≥ 42, < 62 | 7815 | 14.39% | |
| ≥ 62, < 120 | 1049 | 1.93% | |
| Administration dose | 1 | 15,997 | 29.55% |
| 2 | 13,776 | 25.45% | |
| 3 | 11,183 | 20.66% | |
| 4 | 1667 | 3.08% | |
| 5 | 332 | 0.61% | |
| 6 | 133 | 0.25% | |
| 7 + | 41 | 0.08% | |
| Unknown | 10,966 | 20.26% | |
| NA | 41 | 0.08% | |
| Outcome | Died | 872 | 1.61% |
| Life threatening | 1093 | 2.02% | |
| Emergency room | 17,206 | 31.78% | |
| Hospitalized | 3801 | 7.02% | |
| Prolonged hospitalization | 323 | 0.60% | |
| Disability | 1326 | 2.45% | |
| Congenital anomaly or birth defect | 1022 | 1.89% | |
| healthcare professional office/clinic visit | 1302 | 2.41% | |
| Emergency room/department or urgent care | 1250 | 2.31% | |
| Unknown | 31,330 | 57.87% | |
| Onset time(day) | 0 | 26,022 | / |
| > 0, < 30 | 18,853 | / | |
| ≥ 30, < 60 | 985 | / | |
| ≥ 60, < 90 | 443 | / | |
| ≥ 90, < 120 | 307 | / | |
| ≥ 120 | 1631 | / | |
| average | 34.9 | / |
AE adverse event, HBV hepatitis B vaccine, VAERS vaccine adverse event reporting system.